Curtis Noel, MD
The authors reported on 19 patients with 20 total shoulders with minimum two-year follow-up using an augmented glenoid component. They hypothesized the need for augmented glenoids as a way to save bone and prevent medializing the joint line. The average follow-up was 36 months, and the average pre-op retroversion to be corrected was 23.5⁰. The study showed significant improvements in forward elevation and external rotation, while also showing improvements in the SF36 physical form. The implant used in this study was an all-polyethylene, step-cut glenoid with an “anchor peg” for bone growth, in which 12 of the 19 patients showed osseus integration. The conclusion of the authors was that the short-term results are promising for these augmented glenoids, but further research needs to be completed.
I agree with these authors, and others, on the need to address retroversion in total shoulder arthroplasty. Treating the retroverted glenoid is challenging. For these B2 and B3 glenoids, surgeons have limited options. We know that implanting the glenoid in retroversion is not a good option as it increases the edge loading and leads to early loosening and failure. Reaming down the high side and placing a ‘standard’ glenoid can medialize the joint line and places the implant on subcortical bone, which is also not ideal. Using an anatomic total shoulder with an augmented glenoid implant is an attractive option, as it allows the placement of the implant on more solid bone and maintains the joint line. A final option is placing a reverse total shoulder, which may be the best option for some patients.
I currently prefer a wedge augmented glenoid component, instead of a step-cut implant. In my hands, the wedge glenoid is easier to implant and is more bone preserving.